Citation: M. Mazumdar, DERIVATION OF THE BALERIAUX FORMULA OF EXPECTED PRODUCTION COSTS BASED ON CHRONOLOGICAL LOAD CONSIDERATIONS, INTERNATIONAL JOURNAL OF ELECTRICAL POWER AND ENERGY SYSTEMS, 18(1), 1996, pp. 33-36
Citation: M. Mazumdar et al., IN-VITRO MOTILITY FROM RECOMBINANT DYNEIN HEAVY-CHAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 93(13), 1996, pp. 6552-6556
Citation: M. Mazumdar et al., LUMINESCENCE AND DEEP-LEVEL CHARACTERISTICS OF GAAS SI WITH ATOMIC LAYER EPITAXY-GROWN PREDEPOSITION LAYERS/, Journal of applied physics, 79(11), 1996, pp. 8688-8692
Citation: J. Rajgopal et M. Mazumdar, A SYSTEM-BASED COMPONENT TEST PLAN FOR A SERIES SYSTEM, WITH TYPE-II CENSORING, IEEE transactions on reliability, 45(3), 1996, pp. 375-378
Authors:
BREIPOHL AM
ALBRECHT P
ALLAN R
ASGARPOOR S
BHAVARAJU M
BILLINTON R
CURLEY M
HEISING C
MAZUMDAR M
MCCOY M
NIEBO R
PATTON AD
RAU N
RINGLEE R
SCHNEIDER A
SINGH C
WANG L
WARREN M
WONG P
Citation: Am. Breipohl et al., POOLING GENERATING-UNIT DATA FOR IMPROVED ESTIMATES OF PERFORMANCE INDEXES, IEEE transactions on power systems, 10(4), 1995, pp. 1912-1918
Authors:
KELLY WK
SCHER HI
MAZUMDAR M
PFISTER D
CURLEY T
LEIBERTZ C
COHEN L
VLAMIS V
DNISTRIAN A
SCHWARTZ M
Citation: Wk. Kelly et al., SURAMIN AND HYDROCORTISONE - DETERMINING DRUG EFFICACY IN ANDROGEN-INDEPENDENT PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2214-2222
Authors:
MOTZER RJ
SHEINFELD J
MAZUMDAR M
BAJORIN DF
BOSL GJ
HERR H
LYN P
VLAMIS V
Citation: Rj. Motzer et al., ETOPOSIDE AND CISPLATIN ADJUVANT THERAPY FOR PATIENTS WITH PATHOLOGICAL STAGE-II GERM-CELL TUMORS, Journal of clinical oncology, 13(11), 1995, pp. 2700-2704
Authors:
MOTZER RJ
RODRIGUEZ E
REUTER VE
BOSL GJ
MAZUMDAR M
CHAGANTI RSK
Citation: Rj. Motzer et al., MOLECULAR AND CYTOGENETIC STUDIES IN THE DIAGNOSIS OF PATIENTS WITH POORLY DIFFERENTIATED CARCINOMAS OF UNKNOWN PRIMARY SITE, Journal of clinical oncology, 13(1), 1995, pp. 274-282
Citation: M. Mazumdar et A. Kapoor, STOCHASTIC-MODELS FOR POWER-GENERATION SYSTEM PRODUCTION COSTS, Electric power systems research, 35(2), 1995, pp. 93-100
Citation: M. Mazumdar et L. Chrzan, MONTE-CARLO STOCHASTIC SIMULATION OF ELECTRIC-POWER GENERATION SYSTEMPRODUCTION COSTS UNDER TIME-DEPENDENT CONSTRAINTS, Electric power systems research, 35(2), 1995, pp. 101-108
Citation: J. Rajgopal et M. Mazumdar, DESIGNING COMPONENT TEST PLANS FOR SERIES SYSTEM RELIABILITY VIA MATHEMATICAL-PROGRAMMING, Technometrics, 37(2), 1995, pp. 195-212
Authors:
VALLEE RB
VAUGHAN KT
MAZUMDAR M
MIKAMI A
ECHEVERRI C
HUGHES SM
GEE MA
Citation: Rb. Vallee et al., MOLECULAR CHARACTERIZATION OF THE RETROGRADE TRANSPORT MOTOR CYTOPLASMIC DYNEIN, Journal of neurochemistry, 65, 1995, pp. 141-141
Authors:
LAW TM
MOTZER RJ
MAZUMDAR M
SELL KW
WALTHER PJ
OCONNELL M
KHAN A
VLAMIS V
VOGELZANG NJ
BAJORIN DF
Citation: Tm. Law et al., PHASE-III RANDOMIZED TRIAL OF INTERLEUKIN-2 WITH OR WITHOUT LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Cancer, 76(5), 1995, pp. 824-832
Authors:
GOKER E
WALTHAM M
KHERADPOUR A
TRIPPETT T
MAZUMDAR M
ELISSEYEFF Y
SCHNIEDERS B
STEINHERZ P
TAN C
BERMAN E
BERTINO JR
Citation: E. Goker et al., AMPLIFICATION OF THE DIHYDROFOLATE-REDUCTASE GENE IS A MECHANISM OF ACQUIRED-RESISTANCE TO METHOTREXATE IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND IS CORRELATED WITH P53 GENE-MUTATIONS, Blood, 86(2), 1995, pp. 677-684
Authors:
MENCEL PJ
MOTZER RJ
MAZUMDAR M
VLAMIS V
BAJORIN DF
BOSL GJ
Citation: Pj. Mencel et al., ADVANCED SEMINOMA - TREATMENT RESULTS, SURVIVAL, AND PROGNOSTIC FACTORS IN 142 PATIENTS, Journal of clinical oncology, 12(1), 1994, pp. 120-126
Citation: M. Mazumdar, STATISTICAL DISCRIMINATION OF FLOTATION MODELS BASED ON BATCH FLOTATION DATA, International journal of mineral processing, 42(1-2), 1994, pp. 53-73
Authors:
KEMENY N
SEITER K
CONTI JA
COHEN A
BERTINO JR
SIGURDSON ER
BOTET J
CHAPMAN D
MAZUMDAR M
BUDD AJ
Citation: N. Kemeny et al., HEPATIC ARTERIAL FLOXURIDINE AND LEUCOVORIN FOR UNRESECTABLE LIVER METASTASES FROM COLORECTAL-CARCINOMA, Cancer, 73(4), 1994, pp. 1134-1142
Authors:
MURPHY BA
MOTZER RJ
MAZUMDAR M
VLAMIS V
NISSELBAUM J
BAJORIN D
BOSL GJ
Citation: Ba. Murphy et al., SERUM TUMOR-MARKER DECLINE IS AN EARLY PREDICTOR OF TREATMENT OUTCOMEIN GERM-CELL TUMOR PATIENTS TREATED WITH CISPLATIN AND IFOSFAMIDE SALVAGE CHEMOTHERAPY, Cancer, 73(10), 1994, pp. 2520-2526
Authors:
MOTZER RJ
MAZUMDAR M
GULATI SC
BAJORIN DF
LYN P
VLAMIS V
BOSL GJ
Citation: Rj. Motzer et al., PHASE-II TRIAL OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUSBONE-MARROW TRANSPLANTATION IN 1ST-LINE THERAPY FOR PATIENTS WITH POOR-RISK GERM-CELL TUMORS, Journal of the National Cancer Institute, 85(22), 1993, pp. 1828-1835
Authors:
MINASIAN LM
MOTZER RJ
GLUCK L
MAZUMDAR M
VLAMIS V
KROWN SE
Citation: Lm. Minasian et al., INTERFERON ALFA-2A IN ADVANCED RENAL-CELL CARCINOMA - TREATMENT RESULTS AND SURVIVAL IN 159 PATIENTS WITH LONG-TERM FOLLOW-UP, Journal of clinical oncology, 11(7), 1993, pp. 1368-1375